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a b s t r a c t 
Misfolding and aggregation of copper–zinc superoxide dismutase (Sod1) are observed in neurodegenerative 
diseases such as amyotrophic lateral sclerosis (ALS). Mutations in Sod1 lead to familial ALS (FALS), which is a
late-onset disease. Since oxidative damage to proteins increases with age, it had been proposed that oxidation 
of Sod1 mutants may trigger their misfolding and aggregation in FALS. However, over 90% of ALS cases are
sporadic (SALS) with no obvious genetic component. We hypothesized that oxidation could also trigger 
the misfolding and aggregation of wild-type Sod1 and sought to conﬁrm this in a cellular environment. 
Using quiescent, stationary-phase yeast cells as a model for non-dividing motor neurons, we probed for 
post-translational modiﬁcation (PTM) and aggregation of wild-type Sod1 extracted from these cells. By size- 
exclusion chromatography (SEC), we isolated two populations of Sod1 from yeast: a low-molecular weight 
(LMW) fraction that is catalytically active and a catalytically inactive, high-molecular weight (HMW) fraction. 
High-resolution mass spectrometric analysis revealed that LMW Sod1 displays no PTMs but HMW Sod1 is 
oxidized at Cys146 and His71, two critical residues for the stability and folding of the enzyme. HMW Sod1 is
also oxidized at His120, a copper ligand, which will promote loss of this catalytic metal cofactor essential for
SOD activity. Monitoring the ﬂuorescence of a Sod1-green-ﬂuorescent-protein fusion (Sod1-GFP) extracted 
from yeast chromosomally expressing this fusion, we ﬁnd that HMW Sod1-GFP levels increase up to 40-fold in 
old cells. Thus, we speculate that increased misfolding and inclusion into soluble aggregates is a consequence 
of elevated oxidative modiﬁcations of wild-type Sod1 as cells age. Our observations argue that oxidative 
damage to wild-type Sod1 initiates the protein misfolding mechanisms that give rise to SALS. 
c © 2014 The Authors. Published by Elsevier B.V. 
This is an open access article under the CC BY-NC-SA license 
( http: // creativecommons.org / licenses / by-nc-sa / 3.0 / ).  
 ntroduction 
Copper–zinc superoxide dismutase (Sod1) is an abundant, ubiqui- 
ous enzyme found in the cytosol [ 1 ], mitochondria [ 1 , 2 ] and nucleus 
 1 ] of eukaryotic cells. It is critical in the detoxiﬁcation of superoxide 
adicals produced during aerobic respiration and its deletion renders 
ukaryotes hypersensitive to oxygen [ 3 ]. The biophysical properties of 
od1 have been extensively studied since its misfolding and aggrega- 
ion are associated with the development of late-onset neurodegen- 
rative diseases such as Parkinson ’ s, Alzheimer ’ s and Amyotrophic 
ateral Sclerosis (ALS) [ 4 , 5 ]. Notably, close to 180 ALS-associated mu- 
ations have been reported in the human SOD1 gene [ 6 ] and neurotox- 
city is linked to their structural instability. The ALS mutant proteins 
ppear more prone than wild-type Sod1 to aggregation into high 
olecular weight structures that form non-amyloid aggregates [ 4 , 6 –
 ], a hallmark of ALS [ 8 , 9 ]. However, 90% of ALS cases are not linked to
ny known genetic mutation and are classiﬁed as sporadic ALS (SALS). * Corresponding author. 
E-mail address: ann.english@concordia.ca (A.M. English). 
213-2317/ $ - see front matter c © 2014 The Authors. Published by Elsevier B.V. This is an open
y-nc-sa / 3.0 / ). 
ttp://dx.doi.org/10.1016/j.redox.2014.03.005 The protein misfolding mechanisms underlying the development of 
SALS and FALS remain poorly understood. Human Sod1 was demon- 
strated to have prion-like properties that can trigger its aggregation 
[ 10 ], but ALS may be distinct from other late-onset neurodegener- 
ative diseases [ 4 ] in that non-amyloid aggregates contribute to its 
development [ 11 –13 ]. 
Oxidative damage is generally implicated in the misfolding of Sod1 
mutants that cause FALS [ 11 –13 ] and oxidized proteins accumulate 
during cell aging [ 14 , 15 ]. Paradoxically, its dismutase activity that 
forms H 2 O 2 as a product may render Sod1 more susceptible to ox- 
idative PTMs than other proteins [ 7 , 8 ]. The redox-active catalytic Cu 
center of Sod1 displays pseudoperoxidase activity and exposure of 
the enzyme to excess H 2 O 2 in vitro results in selective oxidation of 
Cu-coordinating residues with loss of catalytic activity and oligomer- 
ization [ 7 , 8 , 16 , 17 ] by mechanisms that have not been fully elucidated
[ 18 , 19 ]. Cu is ligated to His46, His48, His120 and His63, which bridges 
Cu to the Zn cofactor ( Fig. 1 ). Zn is additionally coordinated to His71, 
His80 and Asp83 ( Fig. 1 ), and plays an important structural role that 
stabilizes the Sod1 homodimer [ 8 ]. Cys57 and Cys146 form an intra- 
subunit disulﬁde that facilitates coordination of the histidine residues  access article under the CC BY-NC-SA license ( http: // creativecommons.org / licenses / 
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Fig. 1. Active-site residues in Sod1. The catalytic Cu cofactor is coordinated to His46, 
His48, His120 and bridging His63. The structural Zn cofactor is coordinated to His63, 
His71 and His80 as well as aspartic acid Asp83 (not shown). The intrasubunit disulﬁde 
bridge between Cys57 and Cys146 is important in stabilizing the Sod1 homodimer 
[ 7 , 8 , 20 ]. The distances from N  of His120 and His71, and the Cys57–Cys146 disulﬁde 
bridge to the catalytic Cu (2.1, 6.9 and 9.5 A˚, respectively) were measured in the 1.15- ˚A 
resolution crystal structure of human Sod1 (PDB 2V0A). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 to the metal cofactors and also stabilizes the enzyme [ 8 ]. Thus, oxi-
dation of a Zn ligand with loss of the metal [ 11 , 20 ] or disruption of
the Cys57–Cys146 disulﬁde destabilize the enzyme and promote its
aggregation [ 20 ]. Since wild-type Sod1 is oxidized by H 2 O 2 in vitro
[ 16 , 21 ], this could also occur in vivo . Increased oxidative stress has
been associated with both FALS and SALS [ 4 , 22 ], and increased protein
oxidation has been detected by OxyBlot in transgenic mouse models
of ALS [ 4 , 22 , 23 ]. However, oxidized Sod1 does not accumulate in the
livers of aging rats [ 24 ], so despite strong links between oxidative
stress and ALS, oxidative PTMs in Sod1 have not been correlated with
pathogenicity. 
Liver protein turnover is relatively rapid so modiﬁed protein ac-
cumulation in this organ may be less than in other tissues. Thus, in
order to probe for speciﬁc sites of Sod1 oxidation in an aging cellular
environment, we selected stationary-phase yeast. In this state, yeast
cells are non-dividing [ 25 ] and in this respect resemble other quies-
cent cells such as motor neurons [ 26 –29 ]. However, yeast rapidly age
[ 25 ], which allows protein modiﬁcation to be examined over a cell ’ s
lifespan in a matter of weeks rather than years. Furthermore, yeast
and human Sod1 share 70% homology and over 90% identity in their
active-site residues. 
We report here that distinct populations of Sod1 exist in
stationary-phase yeast. A low molecular weight, catalytically active
fraction with the mass ( ˜ 32 kDa) of the native Sod1 dimer (LMW Sod1)
and a soluble, high molecular weight, catalytically inactive fraction,
with a mass over 300 kDa (HMW Sod1). High-resolution mass spec-
trometry (MS) revealed negligible oxidation in LMW Sod1 but HMW
Sod1 was oxidized at residues critical for SOD activity and enzyme sta-
bility, suggesting that oxidative damage may trigger Sod1 inclusioninto soluble HMW aggregates. Furthermore, HMW Sod1-GFP levels
increased dramatically in old yeast chromosomally expressing this
fusion, pointing to increased Sod1 oxidation with age. The possible
relevance of oxidative PTM of Sod1 in SALS development is discussed. 
Materials and methods 
Yeast strains, media, and growth conditions 
The BY4741 Saccharomyces cerevisiae strains used in this study are
listed in Table 1 . Wild-type BY4741 was purchased from the Euro-
pean S. cerevisiae Archive for Functional Analysis (EUROSCARF, Frank-
furt, Germany). The BY4741 strain expressing chromosomal SOD1 C-
terminally tagged with green ﬂuorescent protein was kindly provided
by Prof. Christopher Brett (Department of Biology, Concordia Univer-
sity). The two strains were grown in YPD liquid medium (1% yeast
extract, 2% peptone and 2% glucose) at a ﬂask-to-medium volume ra-
tio of 1:5. The cultures at an initial OD 600 = 0.01 were incubated at
30 ◦C with shaking at 225 rpm. The spent YPD medium was replaced
with 0.85% NaCl solution (w / v) after 72 h to switch cells to stationary
phase, a quiescent, non-dividing state [ 26 –28 ]. 
Preparation of soluble protein extracts 
These were prepared as previously described [ 30 ]. Cells were col-
lected at 2000 g , washed twice with 20 mM potassium phosphate
buffer (KPi, pH 7.0) containing 0.1 mM PMSF, the pellets were sus-
pended in the same buffer ±0.1 M iodoacetamide, and mixed with
an equal volume of acid-washed glass beads. Cell suspensions were
vortexed (4 × 15 s cycles), cell debris was removed by centrifugation
at 13,000 g for 10 min at 4 ◦C, and the total protein concentration in
the supernatants (i.e., the soluble protein extracts) was determined
by the Bradford assay with bovine serum albumin as a standard [ 31 ]. 
Fractionation of soluble protein extracts by size-exclusion 
chromatography (SEC) 
Extracts from wild-type and Sod1-GFP-producing yeast strains
were fractionated by SEC on a Superose 12 HR 10 / 30 column (Amer-
sham; total volume 25 mL; void volume 7 mL; fractionation range
1–300 kDa) coupled to an A¨KTApuriﬁer 10. The SEC column was equi-
librated with 20 mM KPi / 300 mM NaCl (pH 7.0), 1 mL of extract
(0.1–0.4 mg total protein) in 20 mM KPi (pH 7.0) was loaded on the
column, proteins were eluted with the equilibration buffer at a ﬂow
rate of 0.3 mL / min, and detected spectrophotometrically at 280 nm.
SEC fractions of 1 mL were collected and probed for Sod1 by SOD
activity assay and immunodot blotting. Extracts containing Sod1-GFP
were analyzed using the same Superose 12 HR column attached to an
Agilent 1100 HPLC with a ﬂuorescence detector to monitor GFP in the
eluate (ex / em 470 / 520 nm). 
In-gel SOD activity assay 
SOD activity in the SEC fractions was assayed in native polyacry-
lamide gels to separately measure the activity of the Sod1 and Sod2
isoforms present in yeast [ 32 ]. The unfractionated soluble protein
extracts and the SEC fractions containing 1–5 μg total protein were
electrophoresed in 12% resolving gels at 50 mA for 2 h at 4 ◦C. The gels
were incubated for 30 min at 20 ◦C in the dark with a staining solution
(0.17 mM NBT, 6.7 mM TEMED and 0.3 mM riboﬂavin in 100 mM KPi,
pH 7.2), rinsed twice with distilled water and exposed to white light
from a 60-W mercury lamp for 60 min, and scanned on an AlphaIm-
ager (AlphaInnotec) to quantify the optical densities of the negative
bands containing SOD activity by ImageJ software. 
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Table 1 
S. cerevisiae strains used in this study. 
Strain Description Reference 
Wild-type BY4741 MATa his3 Δ1 leu2 Δ0 met15 Δ0 ura3 Δ0 EUROSCARF 
Sod1-GFP expressing strain BY4741 cells with SOD1-GFP This work 
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ymmunodetection of Sod1 in the SEC fractions 
These fractions were probed for Sod1 protein in immunodot blots. 
rieﬂy, a 10 μL drop of the unfractionated soluble protein extract 
r of a SEC fraction containing 5–20 μg protein was spotted onto 
 methanol-soaked PVDF membrane and allowed to dry for 10 min 
t room temperature. The membrane was blocked for 1 h in TBST 
50 mM Tris, 150 mM NaCl and 0.05% Tween 20 v / v, pH 7.6) contain- 
ng 5% skimmed milk (w / v), and incubated with rabbit anti-human 
od1 antibody (Stressgen; dilution 1:1000) in 1% milk / TBST for 3 h 
t room temperature. After washing with TBST, the membrane was 
ncubated for 1 h with goat anti-rabbit HRP-conjugated secondary 
ntibody (BioRad; dilution 1:10,000) diluted in 1% milk / TBST. Sod1- 
ontaining peaks were detected by chemiluminescence using an ECL 
it (Thermo, Fisher) and the membrane was scanned on the AlphaIm- 
ger. 
DS-PAGE and trypsin digestion of SEC fractions 
The SEC fractions containing Sod1 protein were decomplexiﬁed 
y 1D SDS-PAGE under reducing conditions on 6% stacking and 12% 
esolving gels. After 1 h electrophoresis at 120 V, the gels were 
oomassie stained and slices were excised between the 10 and 25-kDa 
W markers that bracket the mass of the Sod1 monomer (16 kDa). In 
his mass range, we selected for aggregates stabilized by non-covalent 
onds (disulﬁdes were reduced) to maximize sequence coverage by 
ass spectrometry as discussed below. Following destaining with 
% acetonitrile in 50 mM aqueous ammonium bicarbonate (pH 7.5), 
roteins in the gel slices were reduced with 10 mM DTT for 30 min 
t 60 ◦C, and alkylated with 55 mM iodoacetamide for 30 min at 
oom temperature. The gel slices were separately incubated overnight 
ith trypsin at 37 ◦C and the peptides were extracted from the gel 
lices with 60% acetonitrile in 50 mM aqueous ammonium bicarbon- 
te (pH 7.5) for analysis by LC–MS. 
C–MS screening for oxidative PTMs in Sod1 
Tryptic peptides (5 μL / injection) were separated on a home-made 
eversed-phase C18 column (0.75 μm ID × 7.5 cm) attached to an 
asy-nLC 1000 (Thermo Scientiﬁc) using a 2–94% acetonitrile gra- 
ient in 0.1% aqueous formic acid at a ﬂow rate of 200 nL / min. The 
anoLC output was directed into the ESI source of an LTQ Orbitrap Ve- 
os mass spectrometer (Thermo Scientiﬁc) and analyzed in full-scan 
ode using the Orbitrap high resolution mass analyzer ( m / z range 
50–3000; resolution 60,000 at m / z 400). Other MS parameters were: 
lectrospray voltage 3 kV, CID collision energy 30 V and heated cap- 
llary temperature 200 ◦C. Precursor ions of the Sod1 peptides were 
elected using a mass exclusion threshold of 10 ppm and subjected 
o MS / MS in the Velos linear ion trap mass analyzer using a mass 
olerance of 0.8 u for the fragment ions. MS / MS fragments with an 
ntensity count of 20 or greater were analyzed using Proteome Dis- 
overer 1.3.0 (Thermo Scientiﬁc) and the Sequest search engine with 
ass ﬁlters for oxidation ( + 16, + 32, + 48 u) of Met, Cys, Trp, Tyr; 
nd Cys alkylation by iodoacetamide ( + 57 u) or acrylamide ( + 71 u). 
equest correlated the MS / MS spectra with peptide sequences in the 
east proteome database downloaded from the NCBI website ( ftp: // ftp.ncbi.nlm.nih.gov / ). For conﬁdent identiﬁcation of Sod1, the follow- 
ing Sequest ﬁlters were implemented: Score > 30, XCorr ≥ 2, False 
Discovery Rate < 0.01 and a minimum of two unique peptides. The 
Score is the probability that the identiﬁed protein is a correct match 
based on a comparison of its experimental and theoretical MS / MS 
spectra. XCorr is the cross-correlation between the theoretical and 
experimental MS / MS spectra of the sequenced peptides. Unique pep- 
tides are those present in Sod1 only and absent from all other proteins 
in the yeast database. Table S1 lists the precursors ion analyzed by 
MS / MS and Tables S2–S4 (Supplementary Information) summarize 
the b and y sequence used to assign the PTMs. 
Results 
Catalytically inactive Sod1 is present in HMW fractions from the SEC 
column 
SEC fractionation of the soluble protein extract from 7-day yeast 
cells yielded four resolved chromatographic peaks (P1–P4, Fig. 2 A) 
and shoulders appear on P3 and P4. Peak P1 is eluted within the 
void volume of the column (7 mL) and hence contains soluble protein 
complexes or aggregates > 300 kDa, the upper limit of the fraction- 
ation range of the Superose column. P2, P3 and P4 are eluted at 12, 
18 and 20 mL, respectively, and contain increasingly smaller soluble 
proteins. SOD activity was detected only in the extract and P3 ( Fig. 2 B, 
upper panel) but immunodot blotting reveals the presence of Sod1 
protein in the extract, P1, P1 ′ (7 and 7.5 mL, respectively) and P3 ( Fig. 
2 B, lower panel). Hence, stationary-phase yeast cells contain HMW 
catalytically inactive populations of soluble Sod1 in addition to the 
expected LMW catalytically active enzyme. 
HMW Sod1 is oxidized at Cys146, His120 and His71 
To determine if PTMs are present in HMW Sod1, we examined 
aliquots of P1 by LC–MS with high mass resolution ( R = 60,000) and 
high mass accuracy ( < 10 ppm). The P1 and P1 ′ fractions in the im- 
munodot blot ( Fig. 2 B, lower panel) both come from the single unre- 
solved SEC peak, P1 ( Fig. 2 ) and were combined for further analysis. 
The SEC peak P1 was subjected to 1D SDS-PAGE under reducing con- 
ditions (0.7 M 2-mercaptoethanol) ( Fig. 3 ), slices were excised from 
the gel, and following in-gel protein digestion, the tryptic peptide 
mixtures were extracted and analyzed by LC–MS / MS. The LWM Sod1 
SEC fraction (P3) was treated in the same manner and a representa- 
tive SDS-PAGE gel in shown in Fig. 3 . Sod1 identiﬁcation by LC–MS of 
its tryptic peptides gave high conﬁdence Scores and ≥77% sequence 
coverage ( Table 2 ). 
Sod1 peptides were present in two gel slices cut from lane P1 
close to the expected MW of the Sod1 monomer (16 kDa) ( Fig. 3 , red 
squares). This suggests that treatment with SDS detergent converts 
HMW Sod1 into LMW species under reducing conditions. Nonethe- 
less, a fraction of HMW Sod exhibits aberrant migration in SDS-PAGE 
since peptides from LMW Sod1 were detected only in the gel slice 
cut from lane P3 below the 15 kDa MW marker ( Fig. 3 ). As expected, 
LMW Sod1 migrates within the mass range (14–17 kDa) reported for 
the native yeast Sod1 monomer in SDS-PAGE gels [ 33 ]. Notably, no 
Sod1 peptides were reliably detected in gel slices containing proteins 
with an apparent MW > 30 kDa (data not shown). 
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Table 2 
LC–MS analysis of Sod1 peptides in P1 and P3 a . 
Sample P1 (R15) P1 (R25) P3 (R15) 
Score b 171 85 96 
% Sequence coverage c 77 84 94 
Unique peptides d 11 / 15 12 / 15 13 / 15 
a The soluble proteins were extracted from three independent cultures, fractionated by SEC ( Fig. 2 A) and SDS-PAGE ( Fig. 3 ), in-gel digested with trypsin and analyzed by LC–MS. P1 
and P3 refer to the Sod1-containing SEC peaks in Fig. 2 A; R15 and R25 refer to the marked regions of the SDS-PAGE gel in Fig. 3 . This table provides representative results from the 
three cultures. 
b The score calculated by the Proteome Discoverer software is the probability that the identiﬁed protein is a correct match based on a comparison of its experimental and theoretical 
MS / MS spectra. Scores were in the range of 65–171 for the three independent experiments. 
c The % sequence coverage corresponds to the number of residues in all the Sod1 peptides detected by MS divided by 154 residues in yeast Sod1. Sequence coverage was in the 
range of 68–94% for the three independent experiments. 
d Unique peptides are those present in Sod1 only and absent from all other proteins in the NCBI yeast database ( ftp: // ftp.ncbi.nlm.nih.gov / ). 
Fig. 2. SEC reveals the presence of HMW and LMW Sod1 populations in the soluble pro- 
tein extract from 7-day stationary-phase yeast cells. (A) Size exclusion chromatogram 
of the extract. A 100- μL aliquot of extract containing 0.4 mg of protein was diluted 
to 1 mL with 20 mM KPi (pH 7.0) and loaded on a Superose 12 HR 10 / 30 column 
(1.0 cm × 30 cm) equilibrated with 20 mM KPi / 300 mM NaCl (pH 7.0) and connected 
to the ¨AKTApuriﬁer. Proteins were eluted with the equilibration buffer at a ﬂow rate of 
0.3 mL / min and detected at 280 nm. The arrows indicate the fractions that were tested 
for immunoreactivity and SOD activity. (B) Upper panel: in-gel Sod1 activity following 
native PAGE of the extract and the SEC fractions each containing 1 μg of total protein. 
Bands were stained with riboﬂavin as a superoxide generator and NBT, which is re- 
duced to formazan in the presence of superoxide [ 32 ]. (B) Lower panel: Sod1 protein 
was detected by immunodot blot in the extract, two fractions of the SEC column void 
volume P1 (7 mL) and P1 ′ (7.5 mL), and in P3 (18 mL). Samples containing 10 μg of 
protein were dotted onto PVDF membranes and probed with rabbit anti-human Sod1 
antibody. See "Materials and methods" section for additional information. Sod1 that 
was eluted in P1, P1 ′ and in P3 is referred to in the text as HMW Sod1 and LMW Sod1, 
respectively. P1 and P1 ′ were combined and treated as a single P1 fraction for LC–MS 
analysis. Proteins were extracted from three independent cultures and representative 
results are presented here. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3. Decomplexation of Sod1-containing SEC fractions by SDS-PAGE. Aliquots 
( ˜ 25 μL) of the P1 and P3 SEC fractions from Fig. 2 A containing 20 μg of protein were 
analyzed by reducing SDS-PAGE. Bands were excised from lanes P1 to P3 of the gel and 
subjected to in-gel tryptic digestion. Digests from the R15 and R25 regions (denoted 
by the red boxes) gave the highest score and Sod1 sequence coverage so Tables 2 and 3 
summarize the LC–MS / MS results for these regions. Extracts from three independent 
cultures were analyzed and the gel shown is representative of the three. Blue lines 
indicate the centers of the MW markers, which are poorly visible in the scanned gel 
(lane MW). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 We next examined the Sod1 tryptic peptides for PTMs. LMW Sod1
peptides were alkylated at cysteine residues by the added iodoac-
etamide and by trace acrylamide in the gel. They were also oxidized
at methionine residues but this likely occurs during sample process-
ing since we frequently ﬁnd oxidized methionine in peptides and in
intact proteins analyzed by LC–MS. Importantly, no peptide deriva-
tives were found in LMW Sod1 that we could attribute to PTMs. Thus,
we assume that LMW Sod1 was not oxidized in vivo , consistent with
its retention of SOD activity ( Fig. 2 B). In contrast, Cys146 is oxidized to
the sulfonic acid in HMW Sod1 ( Fig. 4 A; Table S1 ) that migrates below
the 15 kDa marker in SDS-PAGE ( Fig. 3 ). Although Cys146 and Cys57
form an intrasubunit disulﬁde bond in native mature Sod1, we did not
detect Cys57 modiﬁcation in the samples analyzed. Cys146 was also
oxidized in HMW Sod1 from the iodoacetamide-treated lysates ( Table
3 ) but alkylated in the corresponding LMW Sod1 sample. Hence, we
conclude that Cys146 oxidation is a Sod1 PTM that occurs in intact
cells and is not an artifact of sample preparation. Aberrantly migrating HMW Sod1 cut from lane P1 of the gel above
the 15 kDa marker ( Fig. 3 ) was also found to be oxidized. However, in
this fraction, the targets are His120 and His71 rather than cysteine.
In fact, the Cu ligand His120 is 100% oxidized to oxo-histidine ( Fig.
4 B), which would explain the lack of SOD activity in P1 ( Fig. 2 B, up-
per panel) since H 2 O 2 exposure of puriﬁed Sod1 in solution results
in oxidation of the Cu ligands His46, His48 and His120, and loss of
SOD activity [ 16 , 17 , 21 ]. The Zn ligand, His71, is additionally 100%
oxidized to oxo-histidine in this fraction ( Fig. 4 C; Table S1 ), which
would have decreased the protein ’ s afﬁnity this metal cofactor. Crit-
ically, loss of Zn destabilizes the homodimer interface of Sod1 and
results in monomer aggregation in vitro [ 20 ]. Hence, His71 oxidation
in vivo could have triggered the formation of the HMW Sod1 found in
P1 ( Fig. 2 A). We conclude that there are differential mechanisms of
Sod1 oxidation in stationary-phase yeast that result in its oxidation at
Cys146, His120 or His71. These PTMs result in loss of catalytic activ-
ity and in the formation of soluble HMW Sod1-containing aggregates
that are disrupted by detergent under reducing conditions. 
Screening for HMW Sod1 as yeast cells age 
Since ALS and other neurodegenerative diseases are late-onset
[ 4 , 6 , 7 ], we questioned if HMW Sod1 accumulation increased during
yeast aging. Thus, we monitored Sod1-GFP ﬂuorescence in SEC frac-
tions from stationary-phase yeast cells expressing this fusion protein
over several weeks. HMW Sod1-GFP ﬂuorescence in P1 corresponds
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Fig. 4. HMW Sod1 is oxidized at Cys146, His71 and His120. MS / MS spectrum of the (A) (M + 2 H) 2 + ion at m / z 823.41 of the C-terminal peptide containing Cys146-SO 3 H; (B) 
(M + 3 H) 3 + ion at m / z 738.70 of the oxo-His120 peptide; and (C) (M + 3 H) 3 + ion at m / z 366.84 of the oxo-His71 peptide. The peptide (precursor) ions (green) (see Table S1 and 
sequence above spectra) were fragmented by CID (30 V) to give b (red) and y sequence ions (blue). The smallest visible b or y ion bearing the modiﬁed residue (see Tables S2–S4 ) is 
circled in each spectrum. The peptide ion match (number of y + b ions identiﬁed in the MS / MS spectrum divided by the theoretical number of y + b ions generated by CID) is (A) 
18 / 32, (B) 22 / 80, and (C) 13 / 36. The XCorr values are (A) 2.5, (B) 2.0 and (C) 2.0. The MS operating parameters are given in the "Materials and methods" section. 
t
b
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Co 0.2% of the total Sod1-GFP ﬂuorescence in the SEC fractions as cell 
egin to enter stationary phase (day 3, Fig. 5 A). However, this value 
limbs to 8%, a 40-fold increase, in 30-day cells before dropping signif- 
cantly in 40- and 52-day cells ( Fig. 5 B). Thus, Sod1-GFP aggregation 
ncreases as cell age but HMW Sod1-GFP may be converted in very 
ld cells into insoluble aggregates that would be pelleted prior to SEC 
ractionation. 
iscussion 
A fraction of Sod1 is present in HMW aggregates and possesses 
xidative PTMs in 7-day, stationary-phase yeast cells ( Fig. 4 ; Table 3 ). 
ithin these aggregates Sod1 is catalytically inactive and oxidized at 
ys146 or His71 and His120 ( Fig. 4 ). These three residues are critical for the folding and stability of the Sod1 homodimer, and their oxi- 
dation likely triggers formation of HMW Sod1 that is readily isolated 
from the soluble protein extracts by SEC ( Fig. 2 ). 
The intrasubunit Cys146–Cys57 disulﬁde ( Fig. 1 ) is essential in sta- 
bilizing the active site of Sod1 by orienting the coordinating ligands 
towards the Cu and Zn cofactors [ 34 ]. Notably, Cys146–SO 3 H (hu- 
man Sod1 numbering) was isolated from Parkinson ’ s and Alzheimer ’ s 
brains [ 5 ], and inactive Sod1 from the airway epithelia of asthmatic 
patients displays disruption of the Cys146–Cys57 disulﬁde [ 35 ]. Since 
disulﬁdes are more resistant to oxidation than thiols, Cys146 may 
undergo oxidation in immature Sod1 prior to Cys146–Cys57 disul- 
ﬁde formation. In addition to destabilizing the dimer, such oxidation 
would decrease the SOD activity of cells since the ALS Sod1 C146R 
variant has < 10% of wild-type activity [ 8 ]. Curiously, we did not de- 
tect oxidized Cys57, the disulﬁde partner of Cys146 ( Fig. 1 ), although 
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Table 3 
Summary of oxidative modiﬁcations found in HMW Sod1 from 7-day yeast cells a . 
SDS-PAGE 
R15 region 
SDS-PAGE 
R15 region 
+ IA 
SDS-PAGE 
R25 region 
SDS-PAGE 
R25 region 
+ IA 
% Sequence coverage b 77 78 84 74 
Cys146 c SO 3 H SO 3 H P 
d A / P d 
His120 c None None Oxo-His Oxo-His 
His71 c None None Oxo-His Oxo-His 
a The soluble proteins were extracted from three independent cultures, fractionated by SEC ( Fig. 2 A) and SDS-PAGE ( Fig. 3 ), in-gel digested with trypsin and analyzed by LC–MS. P1 
and P3 refer to the Sod1-containing SEC peaks in Fig. 2 A; R15 and R25 refer to the marked regions of the SDS-PAGE gel in Fig. 3 . This table provides representative results from the 
three cultures. 
b The % sequence coverage corresponds to the number of residues in all the Sod1 peptides detected by MS divided by 154 residues in yeast Sod1. Sequence coverage was in the 
range of 68–94% for the three independent experiments. 
c PTMs at these residues detected in the MS / MS spectra of tryptic peptides ( Fig. 4 ) from HMW Sod1 present in the R15 or R25 region of the SDS-PAGE gel ( Fig. 3 ). MS / MS spectra 
were recorded only for precursor ions found in LC-MS spectra (data not shown) that resulted in > 70% sequence coverage. 
d A / P, acetamide and propionamide adducts formed on reaction of cysteine sulfhydryl with iodoacetamide (IA) when added before cell lysis or with free acrylamide present in the 
gels during SDS-PAGE. 
Fig. 5. HMW Sod1-GFP accumulates as yeast age but declines in very old cells. Soluble protein extracts from cells chromosomally expressing Sod1-GFP were fractionated by SEC 
as described in the legend of Fig. 2 except that the Superose column was coupled to an Agilent 1100 HPLC with a ﬂuorescence detector, and GFP ﬂuorescence was monitored with 
ex / em 470 / 520 nm. (A) Size-exclusion chromatogram of extracts from 3- (black line) and 7-day (green area) cells. LMW Sod1-GFP is present in the intense peaks centered at ˜ 11 mL 
and the inset shows a 100-fold expansion of the HMW Sod1-GFP fractions at 6.5 mL. (B) Variation with cell age of HMW Sod1-GFP as a percentage of the total peak area. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 both cysteines are mutated in FALS [ 6 ]. 
Oxidation of the histidines that bind Sod1 ’ s metal cofactors ( Fig.
1 ) will labilize the metals. Three of the four copper ligands, His46,
His48 and His120 ( Fig. 1 ) that are mutated in FALS [ 6 ] are found to be
oxidized in H 2 O 2 -treated Sod1 in vitro [ 21 ]. Curiously, His120 is the
only Cu ligand we ﬁnd oxidized in our soluble HMW Sod1 fraction
isolated from yeast ( Fig. 4 B). Although no Zn ligands were found be
oxidized by H 2 O 2 in vitro [ 21 ], we discovered that His71, which is not a
reported mutation site in FALS [ 6 ], is a target of oxidative modiﬁcation
in yeast ( Fig. 4 C). Hence, oxidative PTMs could labilize both metal
cofactors in Sod1 and promote its aggregation since Cu loss during
acid denaturation increases the enzyme ’ s kinetic instability [ 36 ] and
Zn loss promotes subunit aggregation in vitro [ 20 ]. 
A copper-bound hydroxyl radical formed during the pseudoperox-
idase activity of Sod1 may mediate oxidation of a copper ligand such
as His120 [ 17 ]. In contrast, a diffusible oxidant such as copper released
from the oxidized enzyme or a carbonate radical formed by the pseu-
doperoxidase activity [ 18 , 19 ] in presence of physiological CO 2 levels
likely oxidizes His71 at 6.1 A˚ from copper ( Fig. 1 ). Notably, we ﬁnd that
both His120 and His71 are present as oxo-histidine in the same HMW
Sod1 fraction, suggesting that these oxidations are somehow coupled.
However, Cys146 oxidation is observed in a different HMW Sod1 frac-
tion, which we proposed above may arise from immature metal-free
Sod1. Although we identiﬁed three sites of oxidative PTMs in Sod1from aged yeast, it is important to emphasize that the protein may
undergo more PTMs. Our current methodology is selective for soluble
aggregates stabilized by non-covalent interactions ( Figs. 2 A and 3 ).
Additional oxidative PTMs may trigger the formation of aggregates
stabilized by covalent interactions that would migrate slowly during
SDS-PAGE or of insoluble aggregates that would be pelleted with cell
debris. 
Neurotoxicity has been associated with the borderline stability
that results in the conversion of Sod1 variants into non-amyloid
aggregates [ 4 ]. However, a FALS-causing human Sod1 mutant with
wild-type stability has recently been identiﬁed [ 37 ], suggesting that
additional genetic and / or environmental factors are responsible for
SALS induction. Clearly, HMW Sod1-GFP sharply increases during the
chronological aging of yeast ( Fig. 5 B), which may reﬂect increased
oxidative damage to the protein as anticipated in old cells [ 14 ]. But if
Sod1 oxidation occurs during normal cell aging, what triggers soluble
HMW Sod1 aggregates to become toxic to motor neurons? This may
involve accumulation of the aggregates in mitochondria followed by
respiratory dysfunction [ 4 , 38 ], co-aggregation of Sod1 with transcrip-
tion factors necessary for neuronal survival [ 4 ] or membrane disrup-
tion [ 4 ]. A cell ’ s capacity to degrade misfolded Sod1 or to immobilize
soluble aggregates into insoluble forms may additionally control the
accumulation of toxic species. 
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itrengths and limitations of the yeast model 
The mechanisms underlying the development of SALS remain un- 
lear but are likely multiple and heterogeneous [ 7 , 8 ]. Of the three 
ites of oxidative PTMs that we identify in Sod1 from stationary- 
hase yeast, only a Cys146 FALS mutant (C146R) has been described 
 6 ]. Also, oxidation of His71 by H 2 O 2 has not been reported in vitro . 
hus, our work has identiﬁed an unexpected oxidative PTM in Sod1 
rom yeast and has additionally suggested two possible independent 
echanisms of Sod1 aggregation involving Cys146 oxidation in the 
mmature protein, and His71 plus His120 oxidation of the mature 
rotein. 
Although disulﬁde cleavage and metal cofactor release [ 7 , 8 ] are 
ssociated with human Sod1 aggregation and ALS, it is critical to es- 
ablish if the PTMs observed here are relevant to disease development. 
od1 has a highly conserved active site, but human and yeast Sod1 
ossess only 70% sequence identity. Thus, we will examine PTMs in 
uman Sod1 from yeast expressing this protein. Another critical issue 
s to distinguish between normal and pathological Sod1 aggregation 
ith age as well as the sequestering of other essential proteins by 
od1 aggregates. To this end we will express aggressive Sod1 FALS 
utants in yeast and examine their PTMs and their aggregates over 
ime. Stationary-phase yeast cells are in a quiescent, non-dividing 
tate like neurons [ 26 ] and exhibit the protein misfolding seen in 
eurodegenerative diseases such as ALS [ 39 ] and Parkinson ’ s disease 
 40 ]. Also, the genetic modiﬁcation of yeast to accelerate or decelerate 
he aging process is well-documented, including strains we charac- 
erized that vary in their production of reactive oxygen species (ROS) 
 41 , 42 ]. We will use these strains to examine how variation in ox- 
dative stress affects Sod1 modiﬁcation as cells age. Such studies can 
e easily performed since yeast cells rapidly age and data can be 
ollected at numerous time points from independent cultures. Addi- 
ionally, to establish if strains expressing Sod1-GFP can be used as 
ndicators of Sod1 aggregation with age ( Fig. 5 ), we will compare ag- 
regation of wild-type protein with its GFP fusion to determine how 
he tag inﬂuences this process. 
onclusions 
PTMs associated with protein misfolding have not been system- 
tically investigated in the cellular environment. By combining SEC 
ith high-performance LC–MS / MS, we discovered that oxidation of 
esidues critical for folding and activity leads to HMW Sod1 forma- 
ion in stationary-phase yeast. Further detailed characterization of 
xidized Sod1 and its aggregation in yeast will provide important in- 
ights into protein misfolding mechanisms driven by oxidative stress 
n aging cells. 
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